Font Size: a A A

The Research Of Market Competition Strategy For Kefmol Biological Medical Technology Company

Posted on:2012-11-11Degree:MasterType:Thesis
Country:ChinaCandidate:B ZhouFull Text:PDF
GTID:2189330332497932Subject:Business Administration
Abstract/Summary:PDF Full Text Request
With the in-depth reform of medical treatment, china medical market will have gre ater development, which meanwhile will produce more opportunities for vitro diagnostic industry as well. However, our medical diagnostic reagents industry concentration is rising, and gradually forms the monopolistic competition market structure. Also, the higher profit level of this industry field leads to the actively involvement of various types of industrial capital both at home and abroad, and thus burgeoning enterprises appears unceasingly and the competition in the industry increases dramatically. In addition, the constant deepening medical reform promotes the medical market to reconstruction as well as guides medical resources to reconfigure, and medical diagnosis reagent product market structure and competition are found in a continuous reformation. Therefore, Only having the advantages of brand, quality, scale, price and research, can diagnosis reagent product class companies better adapt to the constant change of Chinese medical diagnosis market competition structure in the future development.Facing the changes in the external environment, vitro diagnostic industry enterprises in china should adjust good new competition strategy, seize the opportunities and meet the comprehensive historical challenge, thereby enhancing their core competitiveness. This thesis analyzed the basic circumstance of in-vitro-diagnostic industry in China in detail: Including the in-vitro-diagnostic reagent classification and characteristic of diagnostic product, the current situation and the future development of in-vitro-diagnostic industry market in China. It has elaborated the challenge and opportunity which will be faced by domestic in-vitro-diagnostic industry in the developing process.This article takes vitro diagnostic products of Guangzhou Kefmol biological technology Co., LTD. for example, and aims to use strategic management especially competition strategy management system theory to conduct the analysis and diagnosis for external environments and internal ability, in which the maim tools including five competitive forces model. Through the system analysis, we touch straight-tempered on competition strategy choice, and put forward the corresponding strategic choice.
Keywords/Search Tags:Vitro diagnostic, External environments, Internal ability, Competition strategy management
PDF Full Text Request
Related items